BMRA.US Biomerica Inc

Healthcare Health Care Equipment & Supplies USA Stocks
1.36 USD
Close of Nov 14, 2026
1.27 2.94
Market cap
USD 6.25M
P/E
-
P/B
1.64x
ROE
-135.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.

Is BMRA.US undervalued?

Graham number

The Graham number of Biomerica Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biomerica Inc fundamental analysis

No fundamental analysis for Biomerica Inc yet.

Biomerica Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical condi…

Full company profile